CompoAtlas

Zonnic Mint Lozenges (4 mg nicotine lozenges)

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Pyridine, 3-(1-méthyl-2-pyrrolidinyl)-, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:2)

Source : Tartrate de nicotine

Potency : 4 milligramme Nicotine

12.29 milligramme

Non-medicinal ingredients

Eau purifiée, Carbonate de sodium anhydre, Saveur de menthe, Solution de maltitol, Isomalt, Acésulfame-K, Bleu 1

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Pastilleminimum: 8 Tous les jours ; maximum: 15 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

The nicotine in Zonnic Mint relieves craving for nicotine and withdrawal symptoms when you stop smoking and counteracts thereby relapse into smoking in smokers who are motivated to stop; or acts as a temporary aid to those who want to stop smoking cigarettes or break the cigarette habit, when used as part of a smoking cessation program. By means of Zonnic Mint you can reduce the discomfort of withdrawal symptoms, by continuing to provide a small amount of nicotine to your body during a short period of time. The effectiveness of this product is directly related to your motivation to stop smoking. Consult your pharmacist or doctor regarding the availability of smoking cessation programs in your area.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Niconovum AB
NPN or DIN-HM
80064786
Status
Active licence
Licence date
26 October 2015
Revision date
15 June 2023
Form
Pastille
Route of administration
Buccale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80064786

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Zonnic Mint Lozenges (4 mg nicotine lozenges)”, https://compoatlas.com/en/supplements/canada/80064786-zonnic-mint-lozenges-4-mg-nicotine-lozenges, updated 15 June 2023.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line